{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/d348aacb-00cd-4b2d-9b3b-ee9d99cdb735/655cea53a2b4520012035ca7?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Ep 732: Crispr world first: UK approves gene-editing drug","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61ba18761a8cbe923a3cf195/1700587847688-bb084acb1700e3a813cd04fbd3793571.jpeg?height=200","description":"<p>UK regulators have approved the world’s first gene editing therapy for human use. Could it be the start of a healthcare revolution?</p><p><br></p><p>For the premium Tortoise listening experience, curated by our journalists, download the free Tortoise audio app. For early and ad-free access, subscribe to Tortoise+ on Apple Podcasts.</p><p><br></p><p>If you’d like to further support slow journalism and help us build a different kind of newsroom, do consider donating to Tortoise at <a href=\"http://tortoisemedia.com/support-us\" rel=\"noopener noreferrer\" target=\"_blank\">tortoisemedia.com/support-us</a>. Your contributions allow us to investigate, campaign and explore, and to build a newsroom that is responsible and sustainable.</p>","author_name":"The Observer"}